Skip to content

WHWK WHWK Debt-to-equity

Debt-to-equity at other companies

Eli Lilly logo
Eli LillyLLY
1.4×-1.1×
Pfizer logo
PfizerPFE
0.7×0.0×
Regeneron Pharmaceuticals logo
Regeneron PharmaceuticalsREGN
0.1×0.0×
Gilead Sciences logo
Gilead SciencesGILD
0.9×-0.4×
AbbVie logo
AbbVieABBV
46.6×+38.6×
IDEAYA Biosciences, Inc. logo
IDEAYA Biosciences, Inc.IDYA
0.0×

Other financials

Income statement

See full
Revenue--100%
Gross profit--100%
Operating income-$23.5M-54.6%
Net income-$22.2M-130%
EPS (diluted)-$0.32-117%

Balance sheet

See full
Cash & equivalents$34.8M-84.7%
Total debt$833.0K-34.3%
Total equity$116.2M-47.6%
Total assets$127.2M-45.6%

Cash flow

See full
Operating cash flow-$22.2M-87.2%
CapEx--100%
Free cash flow-$22.2M-78.9%

Valuation

See full
Market cap$226.49M+131%

Profitability

See full
Gross margin89.4%+1.0pp
Operating margin-1,601.1%-1,985pp
Net margin-288.3%+61.6pp
FCF margin-1,371.4%-1,730pp

Returns & leverage

See full
Return on equity-68.5%-86.2pp
Current ratio11.4×-7.6×

Where this comes from

Calculated from WHWK’s reported figures.

Based on the most recent quarter.

The official record: WHWK’s 10-K, filed March 12, 2026, on SEC EDGAR. View the filing →

Ask your AI about WHWK's debt-to-equity.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is WHWK's debt-to-equity?
WHWK (WHWK) reported debt-to-equity of 0× in Q4 2024.
How has WHWK's debt-to-equity changed year-over-year?
WHWK's debt-to-equity increased by 32.5% year-over-year, from 0× to 0×.
What is the long-term trend for WHWK's debt-to-equity?
Over 3 years (2021 to 2024), WHWK's debt-to-equity has grown at a 53.5% compound annual growth rate (CAGR), from 0× to 0×.
What does debt-to-equity mean?
Total debt (including capitalized leases and financing obligations) divided by shareholders' equity at the quarter end. Measures how much the company is financed by debt relative to equity.